Allergy & Immunology Doctors in Baldwin Park, CA Accepting Medicare

2 Allergy & Immunology doctors found. Showing 1 - 2

Medhat M. Ragab, MD Allergy & Immunology - Allergy Medicare: Accepting Medicare Assignments Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011

Souheil M. Habbal, MD Allergy & Immunology - Allergy Medicare: Medicare Enrolled Practice Location: 1011 Baldwin Park Blvd, Baldwin Park, CA 91706 Phone: 626-851-1011

News Archive

As health reform win seems close, Reid struggling in Nevada re-election bid

The Wall Street Journal: "In the nation's capital, Senate Majority Leader Harry Reid is on the brink of pushing through a national health program that Democrats rank alongside the creation of Social Security and Medicare.

Improved WIC food packages reduced obesity risk for children, study finds

Sweeping changes designed to make a major federal food assistance program more nutritious for low-income families were effective in reducing obesity risk for 4-year-olds who had been on the program since birth, according to a new study by researchers from Tulane University, the University of California, Los Angeles, and PHFE WIC.

Resignation of McClellan offers him 'golden opportunity' for Medicare reform

The resignation of CMS Administrator Mark McClellan will provide him with "a golden opportunity" to "tell us what to do about Medicare," the "monster of our future," columnist Robert Samuelson writes in a Washington Post opinion piece.

Innovative algorithm for AEDs distinguishes betweeen adult and child arrhythmias

Ventricular Fibrillation (VF) is a series of intense and disordered contractions of the ventricles (they are located in the lower part of the heart). In 40 % of respiratory arrests suffered outside a hospital, it was shown that the first cardiac rhythm corresponds to VF, and the only manner to combat it is with electric discharges provided by defibrillation. This

NOXXON Pharma closes €33 million Series D round of financing

NOXXON Pharma AG, a company focused on the development of mirror image oligonucleotide therapeutics called Spiegelmers®, announced today the successful closing of a €33 million Series D round of financing. The round was led by new investor, NGN Capital, and joined by existing investors TVM Capital, Sofinnova Partners, Edmond de Rothschild Investment Partners, Seventure Partners, VC Fonds Technologie Berlin GmbH, Dow Venture Capital, FCP OP MEDICAL BioHealth-Trends, IBG Beteiligungsgesellschaft Sachsen-Anhalt mbH, the Dieckell Group, and others.

Read more Medical News

› Verified 8 days ago